- The first NFT series designed with REAL cancer cells arrives”, but as a completely new type of medical financing model.
- The project takes microscopic images of real, live cancer cells and transforms them into beautiful works of art to be sold as NFTs.
- The photos, the first of which was taken by Tomasz Cichon and Ryszard Smolarczyk in March, were taken using a confocal microscope.
The freshest, most powerful and positive version of the NFT’s and yes, we are talking about a collaboration between el Institute of Oncology in GliwiceOgilvy, the Alleviate Cancer Foundation and the polish artist Paweł Swanski, ‘Buy My Cancer’.
Which is promoted not only as “the first NFT series designed with REAL cancer cells”but as a completely new type of medical financing model.
HOW MADE FROM REAL CANCER CELLS?
The project takes microscopic images of real, live cancer cells and transforms them into beautiful works of art to sell as NFTs. The photos, the first of which were taken by Tomasz Cichon and Ryszard Smolarczyk in March, they were taken with a confocal microscope. They represent cells from cancer patients at the Institute of Oncology in Gliwice in Poland.
Pawel Swanski, a Warsaw-based artist and designer known for his large-format murals with wavy and complex linesstepped in on the project to transform the photographs into paintings depicting an ivy-like design that suffocates cancer cells.
SWanski created three unique paintings, all of which have become NFTs.
Additional NFTs were made of the video recordings documenting his artistic process. They have been listed on the world’s leading NFT markets, OpenSea and VAST. The project was created with the help of Ogilvy.
What if a patient’s cancer could fund their cure?
“Buy My Cancer” – the first #NFT art series made of real living cancer cells to fund treatment for those suffering from cancer – drops June 9th.
— Ogilvy (@Ogilvy) June 2, 2022
A whole new kind of medical financing model
The funds obtained from the sales of the series will be donated to Alleviate Cancer Foundation and will help finance an expensive cancer therapy known as CAR-T, a cutting-edge and highly effective immunotherapy.
In essence, CAR-T therapy genetically modifies a patient’s existing lymphocytes or immune cells, allowing these cells to recognize and fight cancer cells within the body.
Although the method is relatively new, early clinical trials suggest that CAR-T therapy can cure approximately 40% of patients where other treatments have been ineffective.
Professor Jacek Jassem serves as project supervisor ‘Buy My Cancer’ from a medical point of view. Jassem directs the Department of Oncology and Radiotherapy of the Medical University of Gdansk in PoloniAy is considered a leading expert in radiation oncology and clinical oncology.
In addition, he is a cancer survivor and sees CAR-T therapy as a promising new approach. “I think that the term ‘innovative therapy’ is overused in Poland and generates a lot of unnecessary emotions. However, the CAR-T cell method deserves this description: it is the beginning of a new era in oncology,” he said in a statement.
“I express my opinion not only as a doctor, but also as a patient.”
Unfortunately, the therapy is extremely expensive, costs about $400,000 per patient, And it’s not always covered by insurance. As such, many patients who might be good candidates for treatment find it difficult to afford it.
“CAR-T cells are often the last hope for cancer patients for whom there are no other treatment options. Unfortunately, it is extremely expensive,” explained Professor Sebastian Giebel, who supervised the project together with Jassem.
However, once Swanski’s NFT series has been minted and sold, the project will kick off. Later, participating organizations will launch the #buymycancerchallenge, through which Swanski will nominate the next artist to work on the project. Meanwhile, Professors Giebel and Jassem will turn to other scientists to help create the next series of NFTs.
Like this first collection, upcoming ‘Buy My Cancer’ collections will feature NFTs made from living cancer cells from patients. The project is backed by a number of partners, including NFT marketplace Vast, the crypto fundraising platform The Giving Blockas well as the international law firms Wolf Theiss and Bird & Bird.
The first patient whose cells were imaged for the series is Jakub Burnosa student at the AGH University of Science and Technology in Krakow, Poland.
AMLO analyzes sending Cuban doctors to the Telethon Children’s Rehabilitation Center
Prepared pork rinds, the MOST healthy Mexican appetizer?
Influencer denounces the fatphobia he suffered during his medical consultation